Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Curevac N.V. (NQ: CVAC )

3.290 +0.170 (+5.45%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 5, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,506,916
Open 3.330
Bid (Size) 3.210 (13)
Ask (Size) 3.370 (1)
Prev. Close 3.120
Today's Range 3.170 - 3.470
52wk Range 2.215 - 10.70
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Southwest Airlines Adopts a Poison Pill Plan: 7 Things to Know
Southwest Airlines is in the news Wednesday after the airline company adopted a poison pill to battle activist investor Elliott Management. 
Via InvestorPlace
Why Is DouYu (DOYU) Stock Up 44% Today?
DouYu stock is up on Wednesday after the company announced a special cash dividend for DOYU investors payable in August. 
Via InvestorPlace

Performance

YTD
-21.48%
-21.48%
1 Month
-27.37%
-27.37%
3 Month
+7.52%
+7.52%
6 Month
-24.19%
-24.19%
1 Year
-66.01%
-66.01%

More News

Read More
CureVac Layoffs 2024: What to Know About the Latest CVAC Job Cuts
Via InvestorPlace
Topics Workforce
Exposures Layoff
GOEV Stock: Canoo Receives Fleet Order From Go2 Delivery
Via InvestorPlace
DM Stock Alert: Nano Dimension Is Scooping Up Desktop Metal for $183 Million
Via InvestorPlace
GSK and CureVac to Restructure Collaboration into New Licensing Agreement
Via ACCESSWIRE
CureVac Announces Financial Results for the First Quarter of 2024 and Provides Business Update
Via ACCESSWIRE
CVAC Stock Alert: CureVac Pops on Licensing Deal With GSK
Via InvestorPlace
GSK Buys Full Rights To Investigational Covid-19 And Influenza Vaccines From CureVac For Around $1.5B
Via Benzinga
Exposures COVID-19
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
CureVac Initiates Strategic Restructuring to Align Resources with Focus on High-Value mRNA Pipeline Opportunities
Via ACCESSWIRE
CureVac Announces Voting Results of General Meeting
Via ACCESSWIRE
Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
First Human Death From Bird Flu Strain Puts Vaccine Stocks Back On The Map
Via Benzinga
Ollie's Bargain Outlet Posts Upbeat Earnings, Joins Verint Systems, Guidewire Software And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Why Lands' End Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
CureVac Announces Dosing of First Participant in a Phase 2 Study in Seasonal Influenza; Development in Collaboration with GSK
Via ACCESSWIRE
Analog Devices Posts Strong Earnings, Joins TJX, Williams-Sonoma And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Why XP Shares Are Trading Lower By Around 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Despegar.com Posts Strong Sales, Joins Reddit, Robinhood And Other Big Stocks Moving Higher On Friday
Via Benzinga
CVAC Stock Earnings: CureVac Misses EPS, Misses Revenue for Q4 2023
Via InvestorPlace
3 Stocks to Purge ASAP Before They’re Pulled off Life Support
Via InvestorPlace
Elon Musk Breaks Ranks With GOP By Praising Genetic Engineering Tech That Helped Fight COVID-19: 'Digital Medicine With Incredible Potential'
Via Benzinga
Spirit Airlines Posts Weak Results, Joins Integra LifeSciences, Bowlero And Other Big Stocks Moving Lower On Monday
Via Benzinga
COVID-19 Patent Dispute Sorted: Acuitas Therapeutics and CureVac Reach Settlement In Patent Battle
Via Benzinga
Topics Intellectual Property Lawsuit
Exposures COVID-19 Financial Intellectual Property
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.